Speaker illustration

Associate Professor Michael Holinstat

University of Michigan, Ann Arbor (United States of America)

Member of:

European Society of Cardiology

CS014 is a novel HDAC inhibitor regulating the platelet activity, fibrinolysis and clot stability for prevention of thrombosis without increased risk of bleeding

Event: ESC Congress 2022

Topic: Antiplatelet Drugs

Session: Challenges and advances in antithrombotic therapy

Thumbnail

This platform is supported by

logo Novo Nordisk